The Miami Entrepreneur

Pfizer cuts 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales

Read Time:6 Second

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Pfizer cuts 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales
Next post Op-ed: Money decisions by women will shape the future for the U.S.